Drug Enforcement D-0476-2024

Subpotent Drug

Status

Ongoing

Classification

Class II

Report Date

May 8, 2024

Termination Date

—

Product Information

Product description
Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08
Product quantity
3320 bottles
Reason for recall
Subpotent Drug
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
U.S. Nationwide

Location & Firm

Recalling firm
Imprimis NJOF, LLC
Address
1705 Route 46 Ste 6B

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0476-2024
Event ID
94378
Recall initiation date
April 10, 2024
Center classification date
April 29, 2024
Code info
Lot #: 23JUN031; Exp. 07/03/2024
More code info
—